You are about to leave the Clinical Value website now.

Cancel

hepatocellular carcinoma

12 February 2026

LEAD Perspective: Evaluating GAAD – A Malaysian Multicentre Study

12 February 2026

LEAD Perspective: The Taiwan Liver Story – Hepatitis Elimination and HCC Surveillance

12 February 2026

LEAD Perspective: Asia Pacific Consensus Statement on the clinical and economic utility of biomarker-based algorithms in the early detection and surveillance of HCC

Be the first to receive updates, event opportunities, and thought leadership insights.